Literature DB >> 28993968

Enteral Autonomy with Teduglutide Treatment of Intestinal Failure/Short Bowel Syndrome with Depleted Central Venous Access.

Mohammad M Jami1,2, Russell J Merritt3,4.   

Abstract

Entities:  

Keywords:  Glucagon-like peptide-2; Intestinal failure; Short bowel syndrome; Teduglutide

Mesh：

Substances：

Year:  2017        PMID： 28993968     DOI： 10.1007/s10620-017-4780-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  9 in total

Review 1.  Management of acute intestinal failure.

Authors:  Keith R Gardiner
Journal:  Proc Nutr Soc       Date:  2011-08       Impact factor: 6.297

2.  OPTN/SRTR 2013 Annual Data Report: intestine.

Authors:  J M Smith; M A Skeans; S P Horslen; E B Edwards; A M Harper; J J Snyder; A K Israni; B L Kasiske
Journal:  Am J Transplant       Date:  2015-01       Impact factor: 8.086

Review 3.  Autologous intestinal reconstruction surgery as part of comprehensive management of intestinal failure.

Authors:  Mikko P Pakarinen
Journal:  Pediatr Surg Int       Date:  2015-03-29       Impact factor: 1.827

4.  Acute effects of the glucagon-like peptide 2 analogue, teduglutide, on intestinal adaptation in short bowel syndrome.

Authors:  Thomas Thymann; Barbara Stoll; Lars Mecklenburg; Douglas G Burrin; Andreas Vegge; Niels Qvist; Thomas Eriksen; Palle B Jeppesen; Per T Sangild
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-06       Impact factor: 2.839

Review 5.  Indications for intestinal transplantation: recognizing the scope and limits of total parenteral nutrition.

Authors:  Daniel N Gotthardt; Annika Gauss; Ulrike Zech; Arianeb Mehrabi; Karl Heinz Weiss; Peter Sauer; Wolfgang Stremmel; Markus W Büchler; Peter Schemmer
Journal:  Clin Transplant       Date:  2013 Jul-Aug       Impact factor: 2.863

Review 6.  Gut hormones in the treatment of short-bowel syndrome and intestinal failure.

Authors:  Palle B Jeppesen
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2015-02       Impact factor: 3.243

7.  ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults.

Authors:  Loris Pironi; Jann Arends; Janet Baxter; Federico Bozzetti; Rosa Burgos Peláez; Cristina Cuerda; Alastair Forbes; Simon Gabe; Lyn Gillanders; Mette Holst; Palle Bekker Jeppesen; Francisca Joly; Darlene Kelly; Stanislaw Klek; Øivind Irtun; S W Olde Damink; Marina Panisic; Henrik Højgaard Rasmussen; Michael Staun; Kinga Szczepanek; André Van Gossum; Geert Wanten; Stéphane Michel Schneider; Jon Shaffer
Journal:  Clin Nutr       Date:  2014-09-21       Impact factor: 7.324

8.  Natural history of pediatric intestinal failure: initial report from the Pediatric Intestinal Failure Consortium.

Authors:  Robert H Squires; Christopher Duggan; Daniel H Teitelbaum; Paul W Wales; Jane Balint; Robert Venick; Susan Rhee; Debra Sudan; David Mercer; J Andres Martinez; Beth A Carter; Jason Soden; Simon Horslen; Jeffrey A Rudolph; Samuel Kocoshis; Riccardo Superina; Sharon Lawlor; Tamara Haller; Marcia Kurs-Lasky; Steven H Belle
Journal:  J Pediatr       Date:  2012-05-11       Impact factor: 4.406

9.  Long-Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel Syndrome.

Authors:  Lauren K Schwartz; Stephen J D O'Keefe; Ken Fujioka; Simon M Gabe; Georg Lamprecht; Ulrich-Frank Pape; Benjamin Li; Nader N Youssef; Palle B Jeppesen
Journal:  Clin Transl Gastroenterol       Date:  2016-02-04       Impact factor: 4.488
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.